Key Points
- Insider buying: Johnson Matthey insider Andrew Cosslett bought 6,884 shares on June 3 at an average price of GBX 2,168, for a total of about £149,245.
- Stock performance: The shares were up 0.4% and opened at GBX 2,193.59, trading near their 50-day and 200-day moving averages.
- Analyst sentiment: Brokerages remain generally constructive, with a consensus rating of Moderate Buy and an average target price of GBX 2,298.33.
Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Andrew Cosslett acquired 6,884 shares of the business's stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average price of GBX 2,168 per share, with a total value of £149,245.12.
Johnson Matthey Stock Up 0.4%
Shares of LON JMAT opened at GBX 2,193.59 on Thursday. The company has a 50 day simple moving average of GBX 2,052.83 and a 200-day simple moving average of GBX 2,107.69. The company has a market capitalization of £3.68 billion, a P/E ratio of -33.29, a P/E/G ratio of 49,242.50 and a beta of 0.91. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. Johnson Matthey PLC has a 1 year low of GBX 1,660 and a 1 year high of GBX 2,434.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share (EPS) for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. On average, equities research analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on JMAT. Deutsche Bank Aktiengesellschaft raised their price target on shares of Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the stock a "buy" rating in a report on Friday, May 29th. UBS Group restated a "neutral" rating and set a GBX 2,200 price target on shares of Johnson Matthey in a report on Friday, May 22nd. Jefferies Financial Group restated a "restricted" rating on shares of Johnson Matthey in a report on Friday, May 29th. Finally, Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a "buy" rating in a report on Monday. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of GBX 2,298.33.
Check Out Our Latest Stock Analysis on JMAT
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
